0001104659-24-014618.txt : 20240212
0001104659-24-014618.hdr.sgml : 20240212
20240212160617
ACCESSION NUMBER: 0001104659-24-014618
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240208
FILED AS OF DATE: 20240212
DATE AS OF CHANGE: 20240212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morabito Christopher
CENTRAL INDEX KEY: 0001859284
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37467
FILM NUMBER: 24619893
MAIL ADDRESS:
STREET 1: C/O FULCRUM THERAPEUTICS, INC.
STREET 2: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Astria Therapeutics, Inc.
CENTRAL INDEX KEY: 0001454789
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 STATE STREET
STREET 2: SUITE 1400
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 617-349-1971
MAIL ADDRESS:
STREET 1: 75 STATE STREET
STREET 2: SUITE 1400
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: CATABASIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20090127
4
1
tm245876-6_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-08
0
0001454789
Astria Therapeutics, Inc.
ATXS
0001859284
Morabito Christopher
C/O ASTRIA THERAPEUTICS, INC.
75 STATE STREET, SUITE 1400
BOSTON
MA
02109
0
1
0
0
Chief Medical Officer
0
Stock Option (Right to Buy)
15.26
2024-02-08
4
A
0
175000
0
A
2034-02-07
Common Stock
175000
175000
D
This option was granted on February 8, 2024 and is subject to vesting over a four-year period, with 25% of the 175,000 shares underlying the option upon grant vesting on the first anniversary of February 8, 2024 and the remainder vesting over the ensuing three years in equal monthly installments.
/s/ Noah Clauser, as attorney-in-fact for Christopher Morabito
2024-02-12